Clinical Trials
2 trialsNCT05809024 2023-04-12
Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy
Shandong Cancer Hospital and Institute
Phase 4 Unknown
NCT01660542 2016-11-01
An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer
Yonsei University
Phase 4 Completed